(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 26677.30 | 23721.70 | 12.46 | 26677.30 | 23721.70 | 12.46 | 96639.10 | 88134.40 | 9.65 |
| Other Income | 1366.20 | 1165.80 | 17.19 | 1366.20 | 1165.80 | 17.19 | 5551.70 | 5070.60 | 9.49 |
| PBIDT | 8731.60 | 7370.60 | 18.47 | 8731.60 | 7370.60 | 18.47 | 29795.60 | 26632.60 | 11.88 |
| Interest | 175.20 | 127.90 | 36.98 | 175.20 | 127.90 | 36.98 | 572.90 | 761.10 | -24.73 |
| PBDT | 8556.40 | 7385.60 | 15.85 | 8556.40 | 7385.60 | 15.85 | 27791.80 | 25871.50 | 7.42 |
| Depreciation | 572.20 | 588.90 | -2.84 | 572.20 | 588.90 | -2.84 | 2565.60 | 2836.10 | -9.54 |
| PBT | 7984.20 | 6796.70 | 17.47 | 7984.20 | 6796.70 | 17.47 | 25226.20 | 23035.40 | 9.51 |
| TAX | 2284.40 | 574.10 | 297.91 | 2284.40 | 574.10 | 297.91 | 3375.00 | 2138.20 | 57.84 |
| Deferred Tax | 207.00 | -519.30 | -139.86 | 207.00 | -519.30 | -139.86 | -945.00 | -1363.10 | -30.67 |
| PAT | 5699.80 | 6222.60 | -8.40 | 5699.80 | 6222.60 | -8.40 | 21851.20 | 20897.20 | 4.57 |
| Equity | 239.10 | 239.10 | 0.00 | 239.10 | 239.10 | 0.00 | 239.10 | 239.10 | 0.00 |
| PBIDTM(%) | 32.73 | 31.07 | 5.34 | 32.73 | 31.07 | 5.34 | 30.83 | 30.22 | 2.03 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1900.90 |
| Dr. Reddys Labs. | 1175.00 |
| Cipla | 1426.20 |
| Lupin | 2193.00 |
| Zydus Lifesciences | 1120.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: